This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
M

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favorable Risk mRCC - Real-World Evidence From the IMDC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Martin Zarba
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Martin Zarba
192 views
June 7, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

2024 ASCO® Annual Meeting Insights Hub: GU Videos

20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
09:00
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiratero…

Feat. C. Kyriakopoulos
19:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic…

Feat. S. Halabi
View All

Related Content

AUTOPLAY
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
19:41
Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

22:07
Weill Cornell Medicine Oncology & Hematology

Urothelial Carcinoma: New Developments

Feat. C. Sternberg
10:19
University of Colorado Cancer Center

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Feat. T. Flaig
22:03
Dana-Farber Cancer Institute

RCC Highlights From ASCO® GU 2024

Feat. W. Xu, T. Choueiri
17:33
Benjamin Garmezy

1L Treatment Approaches in aRCC: Current Data, Treatment Selection, …

16:19
OncoAlert

Year in Review: RCC Practice Changing and Practice Informing Trials …

Feat. T. Choueiri
07:10
Viktor Grünwald

Updated Results From the CLEAR Trial: Outcomes of the Combination of…

09:40
UCSF School of Medicine

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

Feat. V. Koshkin
19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha
19:47
Janssen Oncology

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha